Out of the Lab, Into the Factory: Providing Cancer Immunotherapy to the Masses
At Umoja, we know that a cancer immunotherapy is only as good as the patients it reaches. We can do the best, most innovative, most exciting science at the bench, but if the manufacturing process is not scalable, the effort will be too large to ultimately meet the needs of all patients who might benefit. […]
Out of the Lab, Into the Factory: Providing Cancer Immunotherapy to the Masses Read More »